321091
Conceptual Model Development to Understand the Pathway to Depression among Head and Neck Cancer Patients
methods: We conducted literature reviews of existing conceptual models of depression among chronic disease patients and risk factors of depression in cancer patients. Factors that were related to HNC patients were included in the model in relation to both depression and the effects of depression on HNC outcomes.
results: The model pathways showed that both individual and contextual level factors can indirectly lead to depression by affecting social support and risk behaviors, or may directly affect depression outcomes. Additionally, depression diagnosis was also shown to impact treatment decisions and lead to poor survival outcomes.
implications: Depression has been associated with worse treatment outcomes and poorer quality of life in cancer patients. The resulting model can help guide future research in this and other cancer populations, and be used to develop targeted interventions for depression in cancer patients.
Learning Areas:
Social and behavioral sciencesSystems thinking models (conceptual and theoretical models), applications related to public health
Learning Objectives:
Describe the known factors associated with depression development among cancer patients, specifically those with cancers of the head and neck
Identify the potential pathways in which individual and contextual level factors influence depression development in patients with cancers of the head and neck.
Discuss the implication of depression on cancer outcomes in this patient popualtion
Keyword(s): Cancer, Depression
Qualified on the content I am responsible for because: I have a background in mental health and epidemiology, with special training in cancer epidemiology research. My dissertation work focuses on the psychological aspects of head and neck cancers
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.